The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this 3-part series, learn how the revenue cycle can impact your supply chain when embarking on a new software implementation or integration.
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
Webcast
Panelists in Part 4 of the GPO or Local/Self Contracting webcast series focus on what providers should expect from their GPO partners. In a Part 5…
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.